260 related articles for article (PubMed ID: 28490573)
1.
Miyoshi S; Tezuka T; Arimura S; Tomono T; Okada T; Yamanashi Y
EMBO Mol Med; 2017 Jul; 9(7):880-889. PubMed ID: 28490573
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
Arimura S; Okada T; Tezuka T; Chiyo T; Kasahara Y; Yoshimura T; Motomura M; Yoshida N; Beeson D; Takeda S; Yamanashi Y
Science; 2014 Sep; 345(6203):1505-8. PubMed ID: 25237101
[TBL] [Abstract][Full Text] [Related]
3. DOK7 Gene Therapy Enhances Neuromuscular Junction Innervation and Motor Function in Aged Mice.
Ueta R; Sugita S; Minegishi Y; Shimotoyodome A; Ota N; Ogiso N; Eguchi T; Yamanashi Y
iScience; 2020 Aug; 23(8):101385. PubMed ID: 32758427
[TBL] [Abstract][Full Text] [Related]
4. Postnatal knockdown of dok-7 gene expression in mice causes structural defects in neuromuscular synapses and myasthenic pathology.
Eguchi T; Tezuka T; Miyoshi S; Yamanashi Y
Genes Cells; 2016 Jun; 21(6):670-6. PubMed ID: 27091576
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanisms underlying the formation and maintenance of neuromuscular junctions and a possible therapeutic approach.].
Eguchi T; Tezuka T; Miyoshi S; Yamanashi Y
Clin Calcium; 2017; 27(3):413-419. PubMed ID: 28232656
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Dok-7 in skeletal muscle enhances neuromuscular transmission with structural alterations of neuromuscular junctions: Implications in robustness of neuromuscular transmission.
Eguchi T; Tezuka T; Fukudome T; Watanabe Y; Sagara H; Yamanashi Y
Biochem Biophys Res Commun; 2020 Feb; 523(1):214-219. PubMed ID: 31848047
[TBL] [Abstract][Full Text] [Related]
8. AAV9-DOK7 gene therapy reduces disease severity in Smn
Kaifer KA; Villalón E; Smith CE; Simon ME; Marquez J; Hopkins AE; Morcos TI; Lorson CL
Biochem Biophys Res Commun; 2020 Sep; 530(1):107-114. PubMed ID: 32828271
[TBL] [Abstract][Full Text] [Related]
9. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
Martineau É; Arbour D; Vallée J; Robitaille R
J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice.
Bordet T; Lesbordes JC; Rouhani S; Castelnau-Ptakhine L; Schmalbruch H; Haase G; Kahn A
Hum Mol Genet; 2001 Sep; 10(18):1925-33. PubMed ID: 11555629
[TBL] [Abstract][Full Text] [Related]
11. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
12. The carboxyl-terminal region of Dok-7 plays a key, but not essential, role in activation of muscle-specific receptor kinase MuSK and neuromuscular synapse formation.
Ueta R; Tezuka T; Izawa Y; Miyoshi S; Nagatoishi S; Tsumoto K; Yamanashi Y
J Biochem; 2017 Mar; 161(3):269-277. PubMed ID: 28069867
[TBL] [Abstract][Full Text] [Related]
13. Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1
Sengupta-Ghosh A; Dominguez SL; Xie L; Barck KH; Jiang Z; Earr T; Imperio J; Phu L; Budayeva HG; Kirkpatrick DS; Cai H; Eastham-Anderson J; Ngu H; Foreman O; Hedehus M; Reichelt M; Hotzel I; Shang Y; Carano RAD; Ayalon G; Easton A
Neurobiol Dis; 2019 Apr; 124():340-352. PubMed ID: 30528255
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
15. Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody.
Cantor S; Zhang W; Delestrée N; Remédio L; Mentis GZ; Burden SJ
Elife; 2018 Feb; 7():. PubMed ID: 29460776
[TBL] [Abstract][Full Text] [Related]
16. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
[TBL] [Abstract][Full Text] [Related]
17. Muscle Fibers Secrete FGFBP1 to Slow Degeneration of Neuromuscular Synapses during Aging and Progression of ALS.
Taetzsch T; Tenga MJ; Valdez G
J Neurosci; 2017 Jan; 37(1):70-82. PubMed ID: 28053031
[TBL] [Abstract][Full Text] [Related]
18. Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic Muscle.
Moloney EB; Hobo B; De Winter F; Verhaagen J
PLoS One; 2017; 12(1):e0170314. PubMed ID: 28103314
[TBL] [Abstract][Full Text] [Related]
19. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
20. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
